Loading…
Reported covered position: Commerce Committee, 2004-2006
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2018 · fourth_quarter · Q4
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Source: Senate LDA
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Pesticide Registration Improvement Extension Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Various issues related to corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Pesticide Registration Improvement Extension Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Pesticide Registration Improvement Extension Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Various issues related to corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Pesticide Registration Improvement Extension Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Pesticide Registration Improvement Extension Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Pesticide Registration Improvement Extension Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Honest and Open New EPA Science Treatment Act of
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Honest and Open New EPA Science Treatment Act of
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Honest and Open New EPA Science Treatment Act of
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Honest and Open New EPA Science Treatment Act of
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Honest and Open New EPA Science Treatment Act of
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Honest and Open New EPA Science Treatment Act of
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
EPA Science Advisory Board Reform Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
EPA Science Advisory Board Reform Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Consolidated Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Consolidated Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Consolidated Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Consolidated Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Consolidated Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Consolidated Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
American Health Care Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
American Health Care Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
American Health Care Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
American Health Care Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
American Health Care Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
American Health Care Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Protect Medical Innovation Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Protect Medical Innovation Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Protect Medical Innovation Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Protect Medical Innovation Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Protect Medical Innovation Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Protect Medical Innovation Act of 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Fostering Innovation in Medical Imaging Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Fostering Innovation in Medical Imaging Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Fostering Innovation in Medical Imaging Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Fostering Innovation in Medical Imaging Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Fostering Innovation in Medical Imaging Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Fostering Innovation in Medical Imaging Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Servicing Safety and Accountability Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Servicing Safety and Accountability Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Servicing Safety and Accountability Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Servicing Safety and Accountability Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Servicing Safety and Accountability Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Servicing Safety and Accountability Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Safety Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Safety Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Safety Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Safety Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Safety Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Medical Device Safety Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
FDA Reauthorization Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
FDA Reauthorization Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
FDA Reauthorization Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
FDA Reauthorization Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
FDA Reauthorization Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
FDA Reauthorization Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
National Defense Authorization Act for Fiscal Year 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
National Defense Authorization Act for Fiscal Year 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
National Defense Authorization Act for Fiscal Year 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
National Defense Authorization Act for Fiscal Year 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Foreign Investment and Economic Security Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Foreign Investment and Economic Security Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Foreign Investment and Economic Security Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Foreign Investment and Economic Security Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Foreign Investment and Economic Security Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Foreign Investment and Economic Security Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Saving America's Pollinators Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Various issues related to corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Saving America's Pollinators Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Saving America's Pollinators Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Various issues related to corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Saving America's Pollinators Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Saving America's Pollinators Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Saving America's Pollinators Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
SNAP Vitamin and Mineral Improvement Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
SNAP Vitamin and Mineral Improvement Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
SNAP Vitamin and Mineral Improvement Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
SNAP Vitamin and Mineral Improvement Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
SNAP Vitamin and Mineral Improvement Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
SNAP Vitamin and Mineral Improvement Act of 2017
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
HEALTHY KIDS Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
HEALTHY KIDS Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
HEALTHY KIDS Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
HEALTHY KIDS Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. Monitor legislative and administrative action related to Section 301 tariffs. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). Monitor administrative action related to the Review of Controls for Certain Emerging Technologies ANPRM.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Various issues related to corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2018 · second_quarter · 2A
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Monitor legislative and administrative action related to intellectual property protection.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA).
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2018 · third_quarter · Q3
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Monitor legislative and administrative action related to the regulation of biostimulants. Various issues related to corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. Monitor legislative and administrative action related to Section 301 tariffs. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the negotiation of the United States-Mexico-Canada Agreement (USMCA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA).
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Monitor legislative and administrative action related to intellectual property protection.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2018 · second_quarter · Q2
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA).
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
Monitor legislative and administrative action related to intellectual property protection.
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2018 · first_quarter · 1A
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA).
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2018 · first_quarter · Q1
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2017 · fourth_quarter · Q4
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administration action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2017 · third_quarter · Q3
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2017 · second_quarter · Q2
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2017 · first_quarter · Q1
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · fourth_quarter · 4A
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative issues and administrative action related to the chemical industry.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · third_quarter · 3A
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3299, Strengthening Public Health Emergency Response Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · first_quarter · 1A
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · fourth_quarter · Q4
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015. S. 1200, Fairness to Pet Owners Act of 2015. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). H.R. 3174, Fairness to Pet Owners Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · third_quarter · Q3
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · second_quarter · Q2
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3299, Strengthening Public Health Emergency Response Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · first_quarter · 1A
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · first_quarter · Q1
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · fourth_quarter · Q4
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1890, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. S. 998, American Manufacturing Competitiveness Act of 2015. S. 1009, AGOA Extension and Enhancement Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · third_quarter · 3A
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Monitor legislative and administrative action on appropriations and budget.
Monitor legislative and administrative action related to Positive Train Control. H.R. 3651, Positive Train Control Enforcement and Implementation Act of 2015. S. 650, Railroad Safety and Positive Train Control Extension Act. S. 1006, Positive Train Control Safety Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · third_quarter · Q3
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · second_quarter · 2A
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · second_quarter · Q2
Monitor legislative and administrative action related to the Toxic Substances Control Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · first_quarter · Q1
Monitor legislative and administrative action related to the Toxic Substances Control Act.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · fourth_quarter · Q4
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · third_quarter · Q3
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology. S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030. S. 1392, Energy Savings and Industrial Competitiveness Act of 2013. S. 2074, Energy Savings and Industrial Competitiveness Act of 2014. S. 2262, Energy Savings and Industrial Competitiveness Act of 2014. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards. H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · second_quarter · 2A
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79). H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · first_quarter · 1A
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of transparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. oMonitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · second_quarter · Q2
S. 1106, Sensible Accounting to Value Energy Act of 2013. All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency.
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology. S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030. S. 1392, Energy Savings and Industrial Competitiveness Act of 2013. S. 2074, Energy Savings and Industrial Competitiveness Act of 2014. S. 2262, Energy Savings and Industrial Competitiveness Act of 2014. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards. H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · first_quarter · Q1
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment.Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA).
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Monitor legislative issues and administrative action related to the chemical industry.
S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and administrative action related to intellectual property protection.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 1, Tax Cuts and Jobs Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administration action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3921, HEALTHY KIDS Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative issues and administrative action related to the chemical industry.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. S. 951, Regulatory Accountability Act of 2017.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action on appropriations and budget. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides.
S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents.
Monitor legislative and administrative action related to intellectual property protection.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
S. 2794, American Manufacturing Competitiveness Act of 2016. H.R. 4923, American Manufacturing Competitiveness Act of 2016.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015. S. 1200, Fairness to Pet Owners Act of 2015. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). H.R. 3174, Fairness to Pet Owners Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017. H.R. 4974, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017. H.R. 4909, National Defense Authorization Act for Fiscal Year 2017. H.R. 5293, Department of Defense Appropriations Act, 2017.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 34, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3299, Strengthening Public Health Emergency Response Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the International Treaty on Plant Genetic Resource for Food and Agriculture (ITPGRFA). Various issues related to proposed corporate acquisition. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 1559, Pet and Women Safety Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1258, Pet and Women Safety Act of 2015. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to miscellaneous tariff legislation. S. 2794, American Manufacturing Competitiveness Act of 2016. H.R. 4923, American Manufacturing Competitiveness Act of 2016.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017. H.R. 4974, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017. H.R. 4909, National Defense Authorization Act for Fiscal Year 2017. H.R. 5293, Department of Defense Appropriations Act, 2017.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the International Treaty on Plant Genetic Resource for Food and Agriculture (ITPGRFA). Various issues related to proposed corporate acquisition. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 1559, Pet and Women Safety Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1258, Pet and Women Safety Act of 2015. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 998, American Manufacturing Competitiveness Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 34, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3299, Strengthening Public Health Emergency Response Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the International Treaty on Plant Genetic Resource for Food and Agriculture (ITPGRFA). Various issues related to proposed corporate acquisition. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 1559, Pet and Women Safety Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1258, Pet and Women Safety Act of 2015. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative issues and administrative action related to the chemical industry.
S. 2794, American Manufacturing Competitiveness Act of 2016. H.R. 4923, American Manufacturing Competitiveness Act of 2016.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017. H.R. 4974, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017. H.R. 4909, National Defense Authorization Act for Fiscal Year 2017. H.R. 5293, Department of Defense Appropriations Act, 2017.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Monitor legislative and administrative action related to intellectual property protection.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to miscellaneous tariff legislation. S. 2794, American Manufacturing Competitiveness Act of 2016. H.R. 4923, American Manufacturing Competitiveness Act of 2016.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the International Treaty on Plant Genetic Resource for Food and Agriculture (ITPGRFA). Various issues related to proposed corporate acquisition. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 1559, Pet and Women Safety Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1258, Pet and Women Safety Act of 2015. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative issues and administrative action related to the chemical industry.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017. H.R. 4974, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017. H.R. 4909, National Defense Authorization Act for Fiscal Year 2017. H.R. 5293, Department of Defense Appropriations Act, 2017.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3299, Strengthening Public Health Emergency Response Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017. H.R. 4974, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017. H.R. 4909, National Defense Authorization Act for Fiscal Year 2017. H.R. 5293, Department of Defense Appropriations Act, 2017.
Monitor legislative issues and administrative action related to the chemical industry. H.R. 2576, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 998, American Manufacturing Competitiveness Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the International Treaty on Plant Genetic Resource for Food and Agriculture (ITPGRFA). S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 998, American Manufacturing Competitiveness Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 998, American Manufacturing Competitiveness Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Monitor legislative and administrative action on appropriations and budget. House and Senate Agriculture and Related Agencies Appropriations Acts for 2017. House and Senate Interior Department and Related Agencies Appropriations Acts for 2017.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
S. 337, FOIA Improvement Act of 2016. S. 378, Sunshine for Regulatory Decrees and Settlements Act of 2015. H.R. 653, FOIA Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative and administrative action related to intellectual property protection. S. 1137, PATENT Act. H.R. 9, Innovation Act.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 2029, Consolidated Appropriations Act, 2016. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action on appropriations and budget.
Monitor legislative and administrative action related to Positive Train Control. H.R. 3651, Positive Train Control Enforcement and Implementation Act of 2015. S. 650, Railroad Safety and Positive Train Control Extension Act. S. 1006, Positive Train Control Safety Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative and administrative action related to intellectual property protection. S. 1137, PATENT Act. H.R. 9, Innovation Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1890, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. S. 998, American Manufacturing Competitiveness Act of 2015. S. 1009, AGOA Extension and Enhancement Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to Environmental Goods Agreement. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1890, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. H.R. 1891, To extend the African Growth and Opportunity Act, the Generalized System of Preferences, the preferential duty treatment program for Haiti, and for other purposes. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. S. 998, American Manufacturing Competitiveness Act of 2015. S. 1009, AGOA Extension and Enhancement Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and administrative action related to Positive Train Control. H.R. 3651, Positive Train Control Enforcement and Implementation Act of 2015. S. 650, Railroad Safety and Positive Train Control Extension Act. S. 1006, Positive Train Control Safety Act.
Monitor legislative and administrative action related to intellectual property protection. S. 1137, PATENT Act. H.R. 9, Innovation Act.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 644, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Monitor legislative and administrative action on appropriations and budget.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
S.535, Energy Efficiency Improvement Act of 2015 H.R. 896, Regulatory Certainty Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. H.R. 1890, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. S. 998, American Manufacturing Competitiveness Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action on appropriations and budget.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Monitor legislative and administrative action related to the Toxic Substances Control Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
S.535, Energy Efficiency Improvement Act of 2015 H.R. 896, Regulatory Certainty Act of 2015.
Monitor legislative and administrative action on appropriations and budget.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. H.R. 1890, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. H.R. 1907, Trade Facilitation and Trade Enforcement Act of 2015. H.R. 2146, Defending Public Safety Employees' Retirement Act (Title 1 -Bipartisan Congressional Trade Priorities and Accountability Act of 2015). S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015. S. 998, American Manufacturing Competitiveness Act of 2015. S. 1015, Enforcing Orders and Reducing Customs Evasion Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to intellectual property protection.
Monitor legislative and administrative action related to miscellaneous tariff legislation.
Monitor legislative and administrative action on appropriations and budget. S.Con.Res. 11, Budget Resolution. Provisions relating to Medicare policy. H.Con.Res. 27, Budget Resolution. Provisions relating to Medicare policy.
Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
S.535, Energy Efficiency Improvement Act of 2015. H.R. 896, Regulatory Certainty Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to intellectual property protection. H.R. 3309, the Innovation Act.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. Monitor legislative and administrative action related to export classification. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act. S. 2917, Adding Ebola to the FDA Priority Review Voucher Program Act. H.R. 3969, Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act. S. 644, Preventing Abuse of Cough Treatments Act of 2013 or the PACT Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013. H.R. 5447, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to increase the availability of pesticides for the management of parasitic pests that adversely impact the health of managed pollinator bees, and for other purposes.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). Monitor legislative and administrative action related to CMS Competitive Bidding. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology. S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030. S. 1392, Energy Savings and Industrial Competitiveness Act of 2013. S. 2074, Energy Savings and Industrial Competitiveness Act of 2014. S. 2262, Energy Savings and Industrial Competitiveness Act of 2014. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards. H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation. H.R. 523, Protect Medical Innovation Act of 2013. H.R. 2835, Restoring Access to Medication Act of 2013. S. 1647, Restoring Access to Medication Act. S.232, Medical Device Access and Innovation Protection Act.
Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. Monitor legislative issues and bills on Superfund. H.R. 3080, Water Resources Reform and Development Act of 2013. S. 601, Water Resources Development Act of 2013. H.R. 935, Reducing Regulatory Burdens Act of 2014. H.R. 5078, Waters of the United States Regulatory Overreach Protection Act of 2014.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
S.1106 Sensible Accounting to Value Energy Act of 2013. All provisions to sensible accounting to value energy related to mortgages means tested by energy efficiency.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. Monitor legislative issues and bills on Superfund. H.R. 3080, Water Resources Reform and Development Act of 2013. S. 601, Water Resources Development Act of 2013. H.R. 935, Reducing Regulatory Burdens Act of 2014. H.R. 5078, Waters of the United States Regulatory Overreach Protection Act of 2014.
Monitor legislative and administrative action related to intellectual property protection. H.R. 3309, the Innovation Act.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013. H.R. 5447, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to increase the availability of pesticides for the management of parasitic pests that adversely impact the health of managed pollinator bees, and for other purposes.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). Monitor legislative and administrative action related to CMS Competitive Bidding. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology. S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030. S. 1392, Energy Savings and Industrial Competitiveness Act of 2013. S. 2074, Energy Savings and Industrial Competitiveness Act of 2014. S. 2262, Energy Savings and Industrial Competitiveness Act of 2014. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards. H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
Monitor legislative and administrative action related to intellectual property protection. H.R. 3309, the Innovation Act.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. Monitor legislative issues and bills on Superfund. H.R. 3080, Water Resources Reform and Development Act of 2013. S. 601, Water Resources Development Act of 2013.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
Monitor legislative and administrative action related to micellaneous tariff legislation. H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
S. 1106, Sensible Accounting to Value Energy Act of 2013. All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of transparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology. S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030. S. 1392, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards. H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79). H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. Monitor legislative issues and bills on Superfund. H.R. 3080, Water Resources Reform and Development Act of 2013. S. 601, Water Resources Development Act of 2013.
H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action related to miscellaneous tariff legislation. H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation.
S.1106 Sensible Accounting to Value Energy Act of 2013. All provisions to sensible accounting to value energy related to mortgages means tested by energy efficiency.
Monitor legislative and administrative action related to intellectual property protection. H.R. 3309, the Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79). H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. Monitor legislative issues and bills on Superfund. H.R. 3080, Water Resources Reform and Development Act of 2013. S. 601, Water Resources Development Act of 2013.
Monitor legislative and administrative action related to micellaneous tariff legislation. H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Monitor legislative and administrative action related to intellectual property protection. H.R. 3309, the Innovation Act.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to micellaneous tariff legislation. H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment.Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation.
Monitor legislative and administrative action related to intellectual property protection. H.R. 3309, the Innovation Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79).H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015.Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
Monitor legislative and administrative action on chemical facilities regulation. Monitor legislative and administrative action related to the Toxic Substances Control Act. H.R. 3080, Water Resources Reform and Development Act of 2013. S. 601, Water Resources Development Act of 2013.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014.H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
S. 1106, Sensible Accounting to Value Energy Act of 2013. All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency.
H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology. S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030.S. 1392, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards. H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE